Cue Biopharma, Inc. · NASDAQ:CUE
Cue Biopharma, Inc. shareholders
As of Jun 30, 2026, 47 institutions reported holding Cue Biopharma, Inc., 22.6% of its shares. Largest: Bleichroeder LP, Driehaus Capital Management LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cue Biopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Bleichroeder LP | 371K | 5.1% | new | Aug 13, 2026 |
| Driehaus Capital Management LLC | 292K | 4.0% | new | Aug 14, 2026 |
| Vanguard | 188K | 2.6% | new | Aug 13, 2026 |
| Ikarian Capital, LLC | 104K | 1.4% | new | Aug 14, 2026 |
| Tetragon Partners GP Ltd | 93,819 | 1.3% | new | Aug 13, 2026 |
| Stempoint Capital LP | 66,995 | 0.92% | held for review | Aug 14, 2026 |
| BlackRock | 57,807 | 0.80% | new | Aug 7, 2026 |
| ADAR1 Capital Management, LLC | 55,193 | 0.76% | new | Aug 14, 2026 |
| Lion Point Capital, LP | 52,928 | 0.73% | new | Aug 14, 2026 |
| Squadron Capital Management LLC | 50,000 | 0.69% | new | Aug 14, 2026 |